Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.13 USD | -4.68% | +6.42% | +6.42% |
05-20 | Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating | MT |
05-17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.42% | 2.81B | |
+31.62% | 268B | |
+5.00% | 137B | |
+30.81% | 96.16B | |
+7.51% | 92.47B | |
+64.02% | 60.06B | |
+15.24% | 48.02B | |
+25.78% | 37.9B | |
+0.15% | 35.73B | |
+15.12% | 29.23B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- GoodRx Shares Rise as Interim CEO Builds Stake in Company